Related Experiment Video
Updated: Jun 23, 2026

Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro
Published on: July 5, 2017
Improvement of the hypocholesterolemic activities of two common fruit fibers by micronization processing
She-Ching Wu1, Shiuan-Huei Wu, Chi-Fai Chau
1Department of Food Science, National Chiayi University, Chiayi, Taiwan.
Abstract:
This study investigated and compared the potential hypocholesterolemic activities of different insoluble fibers (IFs) prepared from carambola and orange pomace with or without micronization processing. After micronization, the cation-exchange and water-holding capacities of these pectic polysaccharide-rich IFs were effectively increased (from 140 to 180% and from 260 to 290%, respectively). The abilities of these microsized fruit IFs to lower the concentrations of serum triglyceride (by 15.6-17.8%) and serum total cholesterol (by 15.7-17.0%) were significantly (p < 0.05) improved, possibly by means of enhancing the excretion of cholesterol (123-126%) and bile acids (129-133%) in feces. Fecal moisture content was also increased (127-131%) by the consumption of microsized IFs. These results demonstrated that particle size is an important factor in affecting the characteristics and physiological functions of insoluble fibers. The approach of micronization processing might offer the industry an opportunity to improve the physiological functions of food fibers in fiber-rich functional food applications.
More Related Videos
10:37Procedure to Evaluate the Efficiency of Flocculants for the Removal of Dispersed Particles from Plant Extracts
Published on: April 9, 2016
07:42Green Synthesis, Characterization, Encapsulation, and Measurement of the Release Potential of Novel Alkali Lignin Micro-/Submicron Particles
Published on: March 1, 2024
Related Concept Videos
Factors Affecting Dissolution: Particle Size and Effective Surface Area
Bioavailability Enhancement: Drug Permeability Enhancement
Atherosclerosis III: Management
Bioavailability Enhancement: Drug Solubility Enhancement